SLE patients from a Norwegian population treated with steroid or cytotoxic drug showed lower serum levels of TGF-β1 than in controls, and levels of TGF-β1 were related to number of CD4+, CD8+ T cells, and NK cells (98) (Table 1). The gene discussed is TGFB1; the disease is systemic lupus erythematosus.